Associate Clinical Professor of Neurology, UC Davis
Neurology
Dr. Ilkcan Cokgor, MD
|
|
Give Review
Ilkcan Cokgor is an expert in the field of Neurology. She over the years received 1 awards: "Regional Top Doctor". Doctor Ilkcan Cokgor, MD is a published MD. She has 19 papers published. The most current publication "DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma." She accepts Medicare.
Publications
- Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspects.
- Current options for the treatment of neoplastic meningitis.
- Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed ...
- Distributed opticalfiber sensor for spatial location of mode coupling by using the optical Kerr effect.
- Long term response in a patient with neoplastic meningitis secondary to melanoma treated with (131)I-radiolabeled antichondroitin proteoglycan sulfate Mel-14 F(ab')(2)...
- Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant Gliomas.
- Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma.
- Monoclonal antibody therapy of human Gliomas: current status and future approaches.
- Dosimetry and dose-response relationships in newly diagnosed patients with malignant Gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 the...
- Seizures and Creutzfeldt-Jakob Disease. A case report and series review.
- Irinotecan therapy in adults with recurrent or progressive malignant glioma.
- Chemotherapy for adults with malignant glioma.
- Dosimetry of 131I-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant Brain tumors.
- Topotecan treatment of adults with primary malignant glioma. The Brain Tumor Center at Duke.
- Gliomas.
- DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma.
- Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma.
- Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant Gliomas: phase I trial results.
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
- Non-Cosmetic Chemodenervation
Conditions Treated
- Alzheimer's Disease
- Anterior Horn Disease
- Ataxia
- Autonomic Disorders
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Duke University Hospital
Hospital
-
Novato Community Hospital
Drug Facts
| NPI NUMBER | 1235100603 | |
| NPPES Provider LastName | COKGOR | |
| NPPES Provider FirstName | ILKCAN | |
| NPPES Provider ZIPCode | 949042011 | |
| NPPES Provider State | CA | |
| Specialty Description | Neurology | |
| Total Claim Count | 9032.0 | |
| Distinct Opioid Count | 11.0 | |
| Opioid Claim Count | 811.0 | |
| Percent Opioid Claims | 8.98 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1235100603 |
| Last Name Of The Provider | COKGOR |
| First Name Of The Provider | ILKCAN |
| View All |